2.1
Sodium zirconium cyclosilicate (Lokelma, AstraZeneca) is indicated for 'the treatment of hyperkalaemia in adult patients'.
Sodium zirconium cyclosilicate (Lokelma, AstraZeneca) is indicated for 'the treatment of hyperkalaemia in adult patients'.
The dosage schedule is available in the summary of product characteristics for sodium zirconium cyclosilicate.
The list price of sodium zirconium cyclosilicate is £10.40 per 10-g sachet or £5.20 per 5-g sachet (excluding VAT; BNF online accessed October 2025).
Costs may vary in different settings because of negotiated procurement discounts.
For information, the Carbon Reduction Plan for UK carbon emissions is published on AstraZeneca's webpage on sustainability.